Development of a folate-conjugated, pH-responsive magnetic nanocarrier based on graphene oxide-g-poly(N-vinylformamide/allylamine) for doxorubicin drug delivery

In this study, a folic acid-conjugated pH-responsive copolymer grafted onto magnetic carboxylated graphene oxide (MCGO) was developed and evaluated for doxorubicin (DOX) adsorption and release. Functionalization of MCGO with allyl alcohol (AOH) introduced vinyl groups that served as initiation sites for free-radical polymerization and grafting of the N -vinylformamide (VF)/allylamine (AN) chains. Subsequent conjugation of folic acid (FA) was designed to enhance the potential for folate receptor-associated cellular interaction. Structural and physicochemical characterization using FTIR, XRD, BET, TGA, VSM, FE-SEM/EDX, TEM, and zeta potential/DLS analyses confirmed the successful fabrication of the nanocomposite. The surface area and pore volume of MCGO-p(VF/AN)-FA were 82.68 m 2 g −1 and 0.21 cm 3 g −1 , respectively, roughly ten times higher than those of CGO. The synthesized composite exhibited high DOX adsorption capacity under selected conditions (pH: 8, temperature: 55 °C, contact time: 45 min), evaluated via a one-factor-at-a-time approach. Adsorption kinetics followed a pseudo-second-order model, while the Langmuir isotherm provided the best fit, with a maximum adsorption capacity of 126.619 mg g −1 at 55 °C. Drug release studies revealed enhanced release under mildly acidic conditions, with 88% of the DOX released at pH 5.6 over 48 h at 37 °C. in-vitro studies implied a formulation-dependent biological response, with the FA-conjugated nanocarrier showing a numerical trend toward greater cytotoxicity against MDA-MB-231 breast cancer cells compared with the non-folate system, alongside acceptable biocompatibility toward MCF-10A normal cells (>70% viability). In addition, the competitive inhibition assay utilizing free folic acid resulted in a restoration of MDA-MB-231 cell viability to 98.76%, providing supportive evidence for the involvement of FR-mediated cellular interactions. However, direct quantitative uptake and intracellular trafficking remain to be verified by flow cytometry and confocal imaging in future studies.

Authors

Institutions

Publication Details

Journal
Journal of Saudi Chemical Society
Published
2026-11-17
DOI
https://doi.org/10.1007/s44442-026-00139-w
Primary Topic
Nanoparticle-Based Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Development of a folate-conjugated, pH-responsive magnetic nanocarrier based on graphene oxide-g-poly(N-vinylformamide/allylamine) for doxorubicin drug delivery

Mahsasadat Miralinaghi, Amir Heydarinasab, Elham Moniri, Babak Feizi et al.
Journal of Saudi Chemical Society
Nanoparticle-Based Drug Delivery
article

Development of a folate-conjugated, pH-responsive magnetic nanocarrier based on graphene oxide-g-poly(N-vinylformamide/allylamine) for doxorubicin drug delivery

Mahsasadat Miralinaghi, Amir Heydarinasab, Elham Moniri, Babak Feizi, Afshar Eskandarisefat
article en

Abstract

In this study, a folic acid-conjugated pH-responsive copolymer grafted onto magnetic carboxylated graphene oxide (MCGO) was developed and evaluated for doxorubicin (DOX) adsorption and release. Functionalization of MCGO with allyl alcohol (AOH) introduced vinyl groups that served as initiation sites for free-radical polymerization and grafting of the N -vinylformamide (VF)/allylamine (AN) chains. Subsequent conjugation of folic acid (FA) was designed to enhance the potential for folate receptor-associated cellular interaction. Structural and physicochemical characterization using FTIR, XRD, BET, TGA, VSM, FE-SEM/EDX, TEM, and zeta potential/DLS analyses confirmed the successful fabrication of the nanocomposite. The surface area and pore volume of MCGO-p(VF/AN)-FA were 82.68 m 2 g −1 and 0.21 cm 3 g −1 , respectively, roughly ten times higher than those of CGO. The synthesized composite exhibited high DOX adsorption capacity under selected conditions (pH: 8, temperature: 55 °C, contact time: 45 min), evaluated via a one-factor-at-a-time approach. Adsorption kinetics followed a pseudo-second-order model, while the Langmuir isotherm provided the best fit, with a maximum adsorption capacity of 126.619 mg g −1 at 55 °C. Drug release studies revealed enhanced release under mildly acidic conditions, with 88% of the DOX released at pH 5.6 over 48 h at 37 °C. in-vitro studies implied a formulation-dependent biological response, with the FA-conjugated nanocarrier showing a numerical trend toward greater cytotoxicity against MDA-MB-231 breast cancer cells compared with the non-folate system, alongside acceptable biocompatibility toward MCF-10A normal cells (>70% viability). In addition, the competitive inhibition assay utilizing free folic acid resulted in a restoration of MDA-MB-231 cell viability to 98.76%, providing supportive evidence for the involvement of FR-mediated cellular interactions. However, direct quantitative uptake and intracellular trafficking remain to be verified by flow cytometry and confocal imaging in future studies.

Journal of Saudi Chemical SocietyVol. 30(6)
Islamic Azad University, Tehran (IR), Islamic Azad University of Varamin (IR)
Nanoparticle-Based Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon